Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)

被引：65
作者：
Capobianco, M.
Malucchi, S.
di Sapio, A.
Gilli, F.
Sala, A.
Bottero, R.
Marnetto, F.
Bozzo, C. Doriguzzi
Bertolotto, A.
机构：
[1] Ctr Riferimento Reg Sclerosi Multipla & Neurobiol, I-10043 Orbassano, Italy
[2] Osped G Agnelli, SOC Neurol, Pino Torinese, Italy
来源：
NEUROLOGICAL SCIENCES | 2007年 / 28卷 / 04期
关键词：
neuromyelitis optica; Devic's disease; rituximab; treatment;
D O I：
10.1007/s10072-007-0823-z
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We have described two cases of Devic's disease patients treated with rituximab with different outcomes. The results indicate that there may be early unresponsiveness in very aggressive cases. Well designed clinical trials are needed to assess treatment effects in such a rare disease. .
引用
收藏
页码：209 / 211
页数：3
相关论文
共 10 条
[1]   An open label study of the effects of rituximab in neuromyelitis optica [J].
Cree, BAC ;
Lamb, S ;
Morgan, K ;
Chen, A ;
Waubant, E ;
Genain, C .
NEUROLOGY, 2005, 64 (07) :1270-1272
[2]   Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica [J].
Ghezzi, A ;
Bergamaschi, R ;
Martinelli, V ;
Trojano, M ;
Tola, MR ;
Merelli, E ;
Mancardi, L ;
Gallo, P ;
Filippi, M ;
Zaffaroni, M ;
Comi, G .
JOURNAL OF NEUROLOGY, 2004, 251 (01) :47-52
[3]   Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays [J].
Lalive, P. H. ;
Menge, T. ;
Barman, I. ;
Cree, B. A. ;
Genain, C. P. .
NEUROLOGY, 2006, 67 (01) :176-177
[4]   A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis [J].
Lennon, VA ;
Wingerchuk, DM ;
Kryzer, TJ ;
Pittock, SJ ;
Lucchinetti, CF ;
Fujihara, K ;
Nakashima, I ;
Weinshenker, BG .
LANCET, 2004, 364 (9451) :2106-2112
[5]   IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel [J].
Lennon, VA ;
Kryzer, TJ ;
Pittock, SJ ;
Verkman, AS ;
Hinson, SR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04) :473-477
[6]   A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica [J].
Lucchinetti, CF ;
Mandler, RN ;
McGavern, D ;
Bruck, W ;
Gleich, G ;
Ransohoff, RM ;
Trebst, C ;
Weinshenker, B ;
Wingerchuk, D ;
Parisi, JE ;
Lassmann, H .
BRAIN, 2002, 125 :1450-1461
[7]   Study of mitoxantrone for the treatment of recurrent neuromyelitis Optica (Devic disease) [J].
Weinstock-Guttman, Bianca ;
Ramanathan, Murali ;
Lincoff, Norah ;
Napoli, Salvatore Q. ;
Sharma, Jitendra ;
Feichter, Joan ;
Bakshi, Rohit .
ARCHIVES OF NEUROLOGY, 2006, 63 (07) :957-963
[8]   Revised diagnostic criteria for neuromyelitis optica [J].
Wingerchuk, D. M. ;
Lennon, V. A. ;
Pittock, S. J. ;
Lucchinetti, C. F. ;
Weinshenker, B. G. .
NEUROLOGY, 2006, 66 (10) :1485-1489
[9]   Neuromyelitis optica [J].
Wingerchuk D.M. ;
Weinshenker B.G. .
Current Treatment Options in Neurology, 2005, 7 (3) :173-182
[10]   The clinical course of neuromyelitis optica (Devic's syndrome) [J].
Wingerchuk, DM ;
Hogancamp, WF ;
O'Brien, PC ;
Weinshenker, BG .
NEUROLOGY, 1999, 53 (05) :1107-1114
1